These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 36174380)
1. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380 [TBL] [Abstract][Full Text] [Related]
2. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients. Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044 [TBL] [Abstract][Full Text] [Related]
3. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters. Li XY; Zhao ZX; Huang M; Feng R; He CY; Ma C; Luo SH; Fu J; Wen BY; Ren L; Shou JW; Guo F; Chen Y; Gao X; Wang Y; Jiang JD J Transl Med; 2015 Aug; 13():278. PubMed ID: 26310319 [TBL] [Abstract][Full Text] [Related]
4. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556 [TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine. Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876 [TBL] [Abstract][Full Text] [Related]
6. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
7. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice. Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647 [TBL] [Abstract][Full Text] [Related]
8. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3. Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932 [TBL] [Abstract][Full Text] [Related]
9. Strain-level screening of human gut microbes identifies Xu W; Yu J; Yang Y; Li Z; Zhang Y; Zhang F; Wang Q; Xie Y; Zhao B; Wu C Gut Microbes; 2023; 15(1):2228045. PubMed ID: 37408362 [TBL] [Abstract][Full Text] [Related]
10. The Effects of Berberine on the Gut Microbiota in Apc Wang H; Guan L; Li J; Lai M; Wen X Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580 [No Abstract] [Full Text] [Related]
11. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374 [TBL] [Abstract][Full Text] [Related]
12. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797 [TBL] [Abstract][Full Text] [Related]
13. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice. Singh AB; Liu J Sci Rep; 2019 Oct; 9(1):15641. PubMed ID: 31666640 [TBL] [Abstract][Full Text] [Related]
14. Berberine alters gut microbial function through modulation of bile acids. Wolf PG; Devendran S; Doden HL; Ly LK; Moore T; Takei H; Nittono H; Murai T; Kurosawa T; Chlipala GE; Green SJ; Kakiyama G; Kashyap P; McCracken VJ; Gaskins HR; Gillevet PM; Ridlon JM BMC Microbiol; 2021 Jan; 21(1):24. PubMed ID: 33430766 [TBL] [Abstract][Full Text] [Related]
15. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. Chang XX; Yan HM; Xu Q; Xia MF; Bian H; Zhu TF; Gao X Lipids Health Dis; 2012 Jul; 11():86. PubMed ID: 22762542 [TBL] [Abstract][Full Text] [Related]
16. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378 [TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. Li M; Shu X; Xu H; Zhang C; Yang L; Zhang L; Ji G J Transl Med; 2016 Aug; 14(1):237. PubMed ID: 27495782 [TBL] [Abstract][Full Text] [Related]
18. Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. Wu M; Yang S; Wang S; Cao Y; Zhao R; Li X; Xing Y; Liu L Front Pharmacol; 2020; 11():223. PubMed ID: 32231564 [TBL] [Abstract][Full Text] [Related]
19. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704 [TBL] [Abstract][Full Text] [Related]
20. Berberine alleviates cholesterol and bile acid metabolism disorders induced by high cholesterol diet in mice. Wang Q; Shen W; Shao W; Hu H Biochem Biophys Res Commun; 2024 Jul; 719():150088. PubMed ID: 38740003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]